The artificial saliva market was estimated to be worth USD 1.2 billion in 2022, and over the course of the projection period, a CAGR of 14.1% is anticipated. Saliva use was strictly prohibited throughout the pandemic. Saliva that lubricates and moisturises the mouth is known as artificial saliva, and it is helpful for those who experience persistent dry mouth. It works wonders for foul breath and dry mouth.
The increasing incidence of dry mouth syndrome and the application of artificial saliva to prevent dysphagia. The market is expanding because cancer prevention is becoming more common. Global healthcare infrastructure improvement is propelling the market's positive growth at a rapid pace. In the future, artificial saliva will be helpful for a variety of athletic events.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/artificial-saliva-market

Impact of Covid-19
Due to its effectiveness in reducing the symptoms of dry mouth that some COVID-19 patients, particularly those receiving certain therapies or on ventilators, feel, the COVID-19 pandemic has significantly raised the market for artificial saliva. People began to focus more on the virus during the pandemic and less on the other illnesses. Even chronic illnesses like cancer were treated casually during the pandemic, but the market recovered to its pre-pandemic level after the outbreak.
Growth Drivers
Artificial saliva is becoming more and more popular as a mouth moisturizing agent. In emerging nations, oral disorders rank fourth in terms of treatment costs, according to the World Health Organization. The market for artificial saliva is strongly impacted by oral health maintenance costs, which are a significant healthcare concern. The market for artificial saliva is expanding due to the rising number of cancer patients receiving treatment in the form of chemotherapy and radiation therapy globally.
The market is growing as a result of the increasing uses for treating dry mouth. It facilitates speaking and swallowing, lubricates and moisturizes the oral cavity, and lessens discomfort from the mouth. By imitating the antibacterial qualities of real saliva, avoiding tooth decay, and treating gum illnesses that are frequently linked to decreasing saliva, artificial saliva helps maintain good oral hygiene. Saliva use during COVID-19 was strictly prohibited in order to stop the virus from spreading. Artificial saliva market will be helpful in a number of ways.
Segmentation
Product
· Oral Sprays
· Gels
· Oral Liquids
· Oral solutions
· Powder
· Dissolving Liquids
End-User Segmentation
· Adults
· Pediatric
Distribution Channel Segmentation
· Online
· Offline
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Asia Pacific
Key Players
· Cipla INC
· Parnell Pharmaceuticals INC
· Forward Science
· NANOCHEMAZONE
· Fresenius Kabi A.G.
· Biocosmetic laboratories
· Bausch Health Companies INC
· ICPA Health products limited
· Labo
· ratories KIN S.A.
· Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/artificial-saliva-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545